PER2 and neoplasm: Furthermore, the low expression of PER-2 is reportedly negatively linked to poor differentiation, big tumor sizes, high TNM stage, and lymph node metastasis in NSCLC patients; the overexpression of PER-2 inhibits the migration and invasion of NSCLC cell lines [63, 64].